Endocrine research
Growth Hormone Support
Growth-hormone-releasing peptides studied for their effect on the body's own GH production.
Commonly discussed
CJC-1295, ipamorelin, sermorelin
Growth-hormone-releasing peptides studied for their effect on the body's own GH production.
Explored for recovery, performance & healthy aging
Why it matters
Strength and recovery, supported over time — the throughline of GH-support research.
Lifestyle photography — general mood imagery, not a patient photo or a documented result.
— The science, plainly
What it is
These are growth-hormone secretagogues. Sermorelin and CJC-1295 are analogs of growth-hormone-releasing hormone (GHRH); ipamorelin is a selective ghrelin-receptor (GHSR-1a) agonist. Rather than replacing growth hormone, they prompt the pituitary gland to release more of the body's own.
What research explores
Research describes these peptides stimulating pulsatile GH release, with combination protocols studied for a more sustained signal. They are frequently discussed in the context of recovery, body composition, and healthy-aging research.
Regulatory status
Sermorelin was previously FDA-approved for pediatric GH deficiency (the branded product was discontinued) and remains available through 503A compounding pharmacies. CJC-1295 and ipamorelin are compounded peptides without FDA approval. Your provider confirms what is legally available.
This page is general educational background, not medical advice. Platinum peptides are supplied by Peptara Compounds for research and laboratory use only, including veterinary and animal-therapy research, and are not for human consumption. Statements here have not been evaluated by the FDA.